Andere Sprachen ReproCELL Incorporated

Aktien

A1W0R7

JP3974770004

4978

Markt geschlossen - Japan Exchange Andere Börsenplätze 08:00:00 02.05.2024			% 5 Tage	% 1. Jan.
139 ^JPY	-2.11%		+2.96%	-20.57%

2023	ReproCELL Incorporated berichtet über die Ergebnisse für das am 31. März 2023 endende Geschäftsjahr	CI
2022	REPROCELL unterzeichnet eine Vereinbarung zur prospektiven Sammlung von Proben für die Mikrobiom-Studie von IFF	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ReproCELL Incorporated announced that it has received ¥5.3 million in funding from Morgan Stanley MUFG Securities Co., Ltd.	21.12.
ReproCELL Incorporated announced that it expects to receive ¥5.3 million in funding	05.12.
ReproCELL Incorporated Reports Earnings Results for the Full Year Ended March 31, 2023	12.05.23
Clinical Trials: An Evolutionary Perspective	18.01.23
Histocell, S.L. announced that it expects to receive ?0.4 million in funding from ReproCELL Incorporated	08.11.22
ReproCELL Incorporated : 4 ways ex vivo models offer Pharma better alternatives to animal testing	01.11.22
ReproCELL Incorporated : How human fresh tissue models are helping RCD405 achieve regulatory approval	17.08.22
ReproCELL Incorporated : Everything we know about the 5HT1B receptor	21.04.22
REPROCELL Signs Agreement to Prospectively Collect Samples for IFF's Microbiome Study	20.04.22
ReproCELL Incorporated : Skin biopsy and ex vivo culture methods	29.03.22
ReproCELL Incorporated : The influence of the microbiome on inflammatory bowel diease	18.03.22
ReproCELL Incorporated : What is Human Tissue Testing?	14.03.22
ReproCELL Incorporated : co-author paper with IBM showcasing a novel ML driven precision medicine strategy for drug development	08.03.22
ReproCELL Incorporated : Solutions for Skin Disease Researchers	04.03.22
ReproCELL Incorporated : Predicting Psoriasis Drug Efficacy in Human Skin	03.03.22
ReproCELL Incorporated : How SynFire® Technology can benefit your research	03.03.22
ReproCELL Incorporated : Inserts or plates for your 3D cell culture?	28.02.22
ReproCELL Incorporated : How to improve your 3D Cell Culture using Small-scale Perfusion Systems	15.02.22
ReproCELL Incorporated : Biotechgate Digital Partnering 2022 7 - 11 February 2022 • Virtual Meeting	10.02.22
ReproCELL Incorporated : Enhance your epithelial barriers assay using Alvetex	07.02.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ReproCELL Incorporated

Aktien

A1W0R7

JP3974770004

4978

Andere Sprachen

Filter